(3S)-3-cyclopropyl-3-[4-[[5-(2-fluoro-5-methoxy-phenyl)-6-(3,3,3-trifluoropropoxy)pyrazin-2-yl]methoxy]phenyl]propanoic acid

ID: ALA4646784

Chembl Id: CHEMBL4646784

PubChem CID: 156021563

Max Phase: Preclinical

Molecular Formula: C27H26F4N2O5

Molecular Weight: 534.51

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(F)c(-c2ncc(COc3ccc([C@@H](CC(=O)O)C4CC4)cc3)nc2OCCC(F)(F)F)c1

Standard InChI:  InChI=1S/C27H26F4N2O5/c1-36-20-8-9-23(28)22(12-20)25-26(37-11-10-27(29,30)31)33-18(14-32-25)15-38-19-6-4-17(5-7-19)21(13-24(34)35)16-2-3-16/h4-9,12,14,16,21H,2-3,10-11,13,15H2,1H3,(H,34,35)/t21-/m0/s1

Standard InChI Key:  SBMJHYCVGXVXJA-NRFANRHFSA-N

Alternative Forms

  1. Parent:

    ALA4646784

    ---

Associated Targets(Human)

FFAR4 Tchem G-protein coupled receptor 120 (2999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FFAR1 Tchem Free fatty acid receptor 1 (4763 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 534.51Molecular Weight (Monoisotopic): 534.1778AlogP: 6.17#Rotatable Bonds: 12
Polar Surface Area: 90.77Molecular Species: ACIDHBA: 6HBD: 1
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 4.14CX Basic pKa: CX LogP: 5.26CX LogD: 2.17
Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.28Np Likeness Score: -0.53

References

1. Dowarah J, Singh VP..  (2020)  Anti-diabetic drugs recent approaches and advancements.,  28  (5): [PMID:32008883] [10.1016/j.bmc.2019.115263]
2. Kerru N, Singh-Pillay A, Awolade P, Singh P..  (2018)  Current anti-diabetic agents and their molecular targets: A review.,  152  [PMID:29751237] [10.1016/j.ejmech.2018.04.061]

Source